Jacobs Levy Equity Management’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-31,239
| Closed | -$400K | – | 940 |
|
|
2023
Q4 | $400K | Buy |
31,239
+8,563
| +38% | +$110K | ﹤0.01% | 858 |
|
|
2023
Q3 | $839K | Buy |
22,676
+21,999
| +3,249% | +$814K | 0.01% | 701 |
|
|
2023
Q2 | $27.3K | Sell |
677
-25,517
| -97% | -$1.03M | ﹤0.01% | 955 |
|
|
2023
Q1 | $1.9M | Sell |
26,194
-12,337
| -32% | -$894K | 0.01% | 584 |
|
|
2022
Q4 | $3.16M | Buy |
38,531
+24,318
| +171% | +$1.99M | 0.02% | 472 |
|
|
2022
Q3 | $1.34M | Buy |
+14,213
| New | +$1.34M | 0.01% | 644 |
|
|
2021
Q3 | – | Sell |
-4,669
| Closed | -$1.82M | – | 1035 |
|
|
2021
Q2 | $1.82M | Buy |
4,669
+1,918
| +70% | +$746K | 0.01% | 617 |
|
|
2021
Q1 | $988K | Buy |
+2,751
| New | +$988K | 0.01% | 741 |
|
|
2020
Q4 | – | Sell |
-4,702
| Closed | -$1.52M | – | 1014 |
|
|
2020
Q3 | $1.52M | Sell |
4,702
-430
| -8% | -$139K | 0.02% | 569 |
|
|
2020
Q2 | $1.87M | Buy |
5,132
+4,638
| +939% | +$1.69M | 0.02% | 546 |
|
|
2020
Q1 | $105K | Sell |
494
-829
| -63% | -$176K | ﹤0.01% | 958 |
|
|
2019
Q4 | $545K | Buy |
+1,323
| New | +$545K | 0.01% | 774 |
|